Axonics® to participate in svb leerink virtual healthcare conference

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the svb leerink virtual healthcare conference on february 17, 2022. axonics is scheduled to present at 12:00 p.m. eastern time. a live webcast and archived replay of the presentation will be accessible on the axonics investor relations website. about axonics base
AXNX Ratings Summary
AXNX Quant Ranking